NRX Pharmaceuticals, Inc. (NRXP) Financials
NRXP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 13.1 million | 19.3 million |
2023-06-30 | 19.8 million | 22.6 million |
2023-03-31 | 21.8 million | 22.1 million |
2022-12-31 | 25.8 million | 18.4 million |
NRXP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.6 million | 351000 |
2023-06-30 | -7.8 million | 544000 |
2023-03-31 | -6.1 million | 695000 |
2022-12-31 | -8.3 million | 766000 |
NRXP Net Income
No data available :(
NRXP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 8.9 million | - | - |
2023-06-30 | 15.0 million | - | - |
2023-03-31 | 16.5 million | - | - |
2022-12-31 | 20.1 million | - | - |
NRXP Shares Outstanding
NRXP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 2000 | 3.3 million | 2.5 million | - |
2023-06-30 | 2000 | 3.9 million | 4.1 million | - |
2023-03-31 | 4000 | 3.7 million | 5.8 million | - |
2022-12-31 | 1000 | 4.5 million | 5.4 million | - |
NRXP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 2000 |
2023-06-30 | - | 1000 |
2023-03-31 | - | 1000 |
2022-12-31 | - | 1000 |
NRXP
Price: $3.06
52 week price:
Earnings Per Share: -4.00 USD
P/E Ratio: -0.96
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 246900
Market Capitalization: 49.0 million